MELONEX

Each ml contains:
Meloxicam. 5 mg
Excipients. q.s.

Relief of pain and inflammation associated with musculoskeletal disorders (lameness).
Reduction of pain and discomfort during acute mastitis in cattle.
Supportive therapy for BRD (Bovine Respiratory Disease), reducing fever and distress.
Management of pain following surgery and traumatic injuries.
Used to alleviate pain and swelling associated with foot rot.

Meloxicam exerts its therapeutic effects by inhibiting the synthesis of prostaglandins, which are key mediators of inflammation, pain, and fever. It selectively inhibits the enzyme Cyclooxygenase-2 (COX-2) more strongly than Cyclooxygenase-1 (COX-1). COX-2 is primarily responsible for producing prostaglandins at inflammatory sites. By reducing prostaglandin levels, Meloxicam rapidly decreases localized swelling, redness, and pain sensitivity. The selective action helps reduce the incidence of gastrointestinal side effects compared to non-selective NSAIDs.

Rapid and effective relief of pain, inflammation, and pyrexia (fever).
Improved animal welfare and faster return to productivity.
Selective COX-2 inhibition offers better gastrointestinal safety profile.
Easy single-dose administration often provides prolonged relief.
Enhances recovery when used alongside antibiotic therapy.

Cattle/Buffaloes (Adult): 1.0 ml per 40 kg body weight, Intravenous (I.V.) or Subcutaneous (S.C.)
Swine: 1.0 ml per 50 kg body weight, Intramuscular (I.M.)
Typically a single administration is sufficient; follow veterinary guidance for duration.

50 ml, 100 ml vial

Injection